60 Degrees Pharmaceuticals, Inc. (SXTP)
0.8395
-0.01
(-1.12%)
USD |
NASDAQ |
Dec 18, 16:00
0.835
0.00 (0.00%)
After-Hours: 20:00
60 Degrees Pharmaceuticals EPS Diluted (Quarterly): -0.6647 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.316M |
| Revenue (Quarterly) | 0.5286M |
| Total Expenses (Quarterly) | 2.844M |
| Enterprise Value | 6.759M |
| Gross Profit Margin (Quarterly) | -1.72% |
| Profit Margin (Quarterly) | -438.1% |
| Earnings Yield | -872.3% |
| Normalized Earnings Yield | -861.70 |